Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GBT - Pfizer said to have had bidding war with Johnson & Johnson for Global Blood

GBT - Pfizer said to have had bidding war with Johnson & Johnson for Global Blood

Global Blood Therapeutics Inc.

  • Pfizer ( NYSE: PFE ) is said to have been involved in a bidding war with Johnson & Johnson ( NYSE: JNJ ) to acquire Global Blood Therapeutics ( NASDAQ: GBT ) before Pfizer won with its $5.4 billion offer.
  • Johnson & Johnson ( JNJ ) is the unidentified "Company A" in a regulatory filing from Friday, according to a Bloomberg report from late Tuesday.
  • Earlier this month Pfizer ( PFE ) agreed to buy sickle cell disease drug maker Global Blood Therapeutics ( GBT ) for $68.50/share.

For further details see:

Pfizer said to have had bidding war with Johnson & Johnson for Global Blood
Stock Information
Company Name: Global Blood Therapeutics Inc.
Stock Symbol: GBT
Market: NASDAQ
Website: gbt.com
Menu
GBT GBT Quote GBT Short GBT News GBT Articles GBT Message Board
Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...